<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Fantel, Anna-Maria</dc:creator>
  <dc:creator>Myrianthopoulos, Vassilios</dc:creator>
  <dc:creator>Georgoulis, Anastasios</dc:creator>
  <dc:creator>Lougiakis, Nikolaos</dc:creator>
  <dc:creator>Zantza, Iliana</dc:creator>
  <dc:creator>Lamprinidis, George</dc:creator>
  <dc:creator>Augsburger, Fiona</dc:creator>
  <dc:creator>Marakos, Panagiotis</dc:creator>
  <dc:creator>Vorgias, Constantinos E.</dc:creator>
  <dc:creator>Szabo, Csaba</dc:creator>
  <dc:creator>Pouli, Nicole</dc:creator>
  <dc:creator>Papapetropoulos, Andreas</dc:creator>
  <dc:creator>Mikros, Emmanuel</dc:creator>
  <dc:date>2020-08-16</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Cystathionine β-synthase (CBS) is a key enzyme in the production of the signaling  molecule hydrogen sulfide, deregulation of which is known to contribute to a range of  serious pathological states. Involvement of hydrogen sulfide in pathways of  paramount importance for cellular homeostasis renders CBS a promising drug target.  An in-house focused library of heteroaromatic compounds was screened for CBS  modulators by the methylene blue assay and a pyrazolopyridine derivative with a  promising CBS inhibitory potential was discovered. The compound activity was readily  comparable to the most potent CBS inhibitor currently known, aminoacetic acid, while  a promising specificity over the related cystathionine γ-lyase was identified. To rule out  any possibility that the inhibitor may bind the enzyme regulatory domain due to its  high structural similarity with cofactor s-adenosylmethionine, differential scanning  fluorimetry was employed. A sub-scaffold search guided follow-up screening of related  compounds, providing preliminary structure-activity relationships with respect to  requisites for efficient CBS inhibition by this group of heterocycles. Subsequently, a  hypothesis regarding the exact binding mode of the inhibitor was devised on the basis  of the available structure-activity relationships (SAR) and a deep neural networks  analysis and further supported by induced-fit docking calculations.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/309156</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/309156/files/sza_shs.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.3390/molecules25163739</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Molecules. - 2020, vol. 25, no. 16, p. 3739</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Screening of heteroaromatic scaffolds against cystathionine beta-synthase enables identification of substituted pyrazolo[3,4-c]pyridines as potent and selective orthosteric inhibitors</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
